Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery
DOI:
https://doi.org/10.2340/actadv.v104.21502Keywords:
Vogt-Koyanagi Hatrada disease, Th2 immunity, Th1 immunity, COVID-19 vaccination, vitiligoAbstract
Abstract is missing (Short communication)
Downloads
References
Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol 2005; 20: 183-190.
https://doi.org/10.1080/08820530500232126 DOI: https://doi.org/10.1080/08820530500232126
Xu K, Gao B, Li J, Xiang Y, Cao L, Zhao M. Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease. Hum Vaccin Immunother 2023; 19: 2220630.
https://doi.org/10.1080/21645515.2023.2220630 DOI: https://doi.org/10.1080/21645515.2023.2220630
Lim JA, Tan WC, Nor NM. Hints from the skin beneath: vitiligo in Vogt-Koyanagi-Harada disease. Dermatol Sin 2022; 40: 78-84.
https://doi.org/10.4103/ds.ds_23_22 DOI: https://doi.org/10.4103/ds.ds_23_22
De Domingo B, López M, Lopez-Valladares M, Ortegon-Aguilar E, Sopeña-Perez-Argüelles B, Gonzalez F. Vogt-Koyanagi-Harada disease exacerbation associated with COVID-19 vaccine. Cells 2022; 11: 1012.
https://doi.org/10.3390/cells11061012 DOI: https://doi.org/10.3390/cells11061012
Tsai T-F, Ng CY. COVID-19 vaccine-associated vitiligo: a cross-sectional study in a tertiary referral center and systematic review. J Dermatol 2023; 50: 982-989.
https://doi.org/10.1111/1346-8138.16799 DOI: https://doi.org/10.1111/1346-8138.16799
Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 1996; 80: 1002-1008.
https://doi.org/10.1136/bjo.80.11.1002 DOI: https://doi.org/10.1136/bjo.80.11.1002
Sugita S, Sagawa K, Mochizuki M, Shichijo S, Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol 1996: 8: 799-803.
https://doi.org/10.1093/intimm/8.5.799 DOI: https://doi.org/10.1093/intimm/8.5.799
Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis 2016; 11: 29.
https://doi.org/10.1186/s13023-016-0412-4 DOI: https://doi.org/10.1186/s13023-016-0412-4
Okada T, Sakamoto T, Ishibashi T, Inomata H. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site. Graefes Arch Clin Exp Ophthalmol 1996; 234: 359-363.
https://doi.org/10.1007/BF00190711 DOI: https://doi.org/10.1007/BF00190711
Chen J, Li S, Li C. Mechanisms of melanocyte death in vitiligo. Med Res Rev 2021; 41: 1138-1166.
https://doi.org/10.1002/med.21754 DOI: https://doi.org/10.1002/med.21754
Mancha D, Antunes J, Soares-de-Almeida L, Borges-Costa J, Filipe P. Localized vitiligo and post-inflammatory hypopigmentation at the injection site of a COVID-19 mRNA vaccine. Dermatol Pract Concept 2023; 13: e2023023.
https://doi.org/10.5826/dpc.1301a23 DOI: https://doi.org/10.5826/dpc.1301a23
Tsuruta D, Hamada T, Teramae H, Mito H, Ishii M. Inflammatory vitiligo in Vogt-Koyanagi-Harada disease. J Am Acad Dermatol 2001; 44: 129-131.
https://doi.org/10.1067/mjd.2001.110879 DOI: https://doi.org/10.1067/mjd.2001.110879
Speeckaert R, Belpaire A, Speeckaert MM, van Geel N. A meta-analysis of chemokines in vitiligo: recruiting immune cells towards melanocytes. Front Immunol 2023; 14: 1112811.
https://doi.org/10.3389/fimmu.2023.1112811 DOI: https://doi.org/10.3389/fimmu.2023.1112811
Bigenwald C, Haddad Y, Thelemaque C, Carrier A, Birebent R, Ly P, et al. RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies. Oncoimmunology 2023; 12: 2163785.
https://doi.org/10.1080/2162402X.2022.2163785 DOI: https://doi.org/10.1080/2162402X.2022.2163785
Haddadi NS, Mande P, Brodeur TY, Hao K, Ryan GE, Moses S, et al. Th2 to Th1 transition is required for induction of skin lesions in an inducible and recurrent murine model of cutaneous lupus-like inflammation. Front Immunol 2022; 13: 883375.
https://doi.org/10.3389/fimmu.2022.883375 DOI: https://doi.org/10.3389/fimmu.2022.883375
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Yasuaki Ikuno, Akihiko Yamaguchi, Toshifumi Takahashi, Noriki Fujimoto
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
